Immuron (IMRN) Exchange Rate Effect (2016 - 2024)
Immuron (IMRN) posted quarterly Exchange Rate Effect of $39482.6 for Q4 2024, up 183.31% year-over-year from $13936.4 in Q1 2024, and up 183.31% quarter-over-quarter from -$47394.7 in Q4 2023.
Immuron (IMRN) Exchange Rate Effect (2016 - 2024) Analysis & Trends
Immuron's Exchange Rate Effect history runs 9 years deep, the most recent figure standing at $39482.6 for Q4 2024.
- In Q4 2024, Exchange Rate Effect rose 183.31% year-over-year to $39482.6; the TTM figure through Dec 2024 stood at -$535877.9 (up 57.87% YoY), while the FY2025 annual figure was $10825.0, down 78.04% from the prior year.
- Exchange Rate Effect for Q4 2024 stood at $39482.6, up from -$47394.7 in the prior quarter.
- The five-year high for Exchange Rate Effect was $39482.6 in Q4 2024, with the low at -$696559.0 in Q4 2020.
- The 5-year median for Exchange Rate Effect is -$47394.7 (2023), against an average of -$246487.4.
- The sharpest annual moves came in 2020 and 2024: Exchange Rate Effect slumped 3238.36% in 2020, then soared 183.31% in 2024.
- Immuron's Exchange Rate Effect stood at -$696559.0 in 2020, then grew by 26.8% to -$509893.8 in 2021, then surged by 96.46% to -$18072.0 in 2022, then sank by 162.25% to -$47394.7 in 2023, then jumped by 183.31% to $39482.6 in 2024.
- Business Quant data shows IMRN's Exchange Rate Effect at $39482.6 in Q4 2024, -$47394.7 in Q4 2023, and -$18072.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 39,482.63 |
| Dec 31, 2024 | 39,482.63 |
| Dec 31, 2023 | -47,394.71 |
| Dec 31, 2023 | -47,394.71 |
| Dec 31, 2022 | -18,072.00 |
| Dec 31, 2022 | -18,072.00 |
| Dec 31, 2021 | -509,893.78 |
| Dec 31, 2021 | -509,893.78 |
| Dec 31, 2020 | -696,559.00 |
| Dec 31, 2020 | -696,559.00 |
| Dec 31, 2019 | 22,195.00 |
| Dec 31, 2019 | 22,195.00 |
| Dec 31, 2018 | -112,270.00 |
| Dec 31, 2018 | -112,270.00 |
| Dec 31, 2017 | 22,040.59 |
| Dec 31, 2017 | 22,040.59 |
| Dec 31, 2016 | 110.83 |
| Dec 31, 2016 | 110.83 |